-
AstraZeneca, RDIF evince interest in Telangana’s global tender for Covid-19 vaccine
Telangana recently issued a global-tender notice for procuring ten million doses of Covid-19 vaccine from manufacturers or their agents in case of imp
-
AstraZeneca Pharma India Q4 net profit up nearly three-fold to Rs 27.27 crore
AstraZeneca Pharma India's revenue from operations of the company stood at Rs 210.25 crore for the quarter under consideration
-
Two doses of Oxford-AstraZeneca vaccine are 85-90% effective, real-world study finds
New analysis for the first time estimates that two doses of the Oxford-AstraZeneca vaccine provide around 85 to 90% protection against covid-19.
-
COVID: AstraZeneca pledges $250,000 as humanitarian aid to India
The aid to India is part of the $1 million which the British-Swedish multinational has earmarked for relief initiatives across communities that have b
-
Covid-19: USTR in talks with Pfizer, AstraZeneca over TRIPS waiver on vaccines
The virtual meeting was set up to discuss increasing vaccine production, global health issues, and the proposed waiver to certain provisions of the WT
-
Legal action against Covishield maker in EU for delivery failure
AstraZeneca vaccine has been central to Europe's immunisation campaign, and a linchpin in the global strategy to get vaccines to poorer countries
-
In spite of the Covid surge, India’s vaccine diplomacy is the right thing to do
Countries cannot build the goodwill necessary for a peaceful rise without displaying a certain degree of selflessness
-
Serum Institute of India defends Covid vaccine pricing, says initial rates based on advance funding
SII, which manufactures AstraZeneca's vaccine Covishield at its Pune facility, earlier this week announced a price of Rs 600 per dose and at Rs 400 fo
-
Covid-19 cases: Pressure mounts on Biden admin to ship AstraZeneca vaccine, other medical supplies to India
The Washington Post in a lead editorial hoped that all of India can seize the moment and begin to reverse the course of this disaster
-
Vaccine for all adults will may soon open door for these pharma players
Any individual above 18 years of age will be eligible to get vaccinated against Covid-19 from May 1
